{
    "code": "12016889",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=12016889",
    "time": "2020-02-26 02:30:08",
    "許可證字號": "內衛藥製字第016889號",
    "註銷狀態": "已註銷",
    "註銷日期": "78\/11\/21",
    "註銷理由": "自請註銷",
    "有效日期": "75\/03\/16",
    "發證日期": "60\/03\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY01201688902",
    "中文品名": "硫酸甲基新斯狄格明注射液",
    "英文品名": "NEOSTIGMINE METHYLSULFATE INJ. &quot;N.Y.&quot;",
    "適應症": "小腸塞＊痛、膀胱鬆弛、重症肌無力",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "1006302200  紐約化學藥品股份有限公司",
        "申請商地址": "台北市中山區漢口街一段１１０號４樓之１５",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1204000920",
            "成分名稱": "NEOSTIGMINE METHYLSULFATE",
            "含量描述": "0.25",
            "含量": "0.2500000000",
            "單位": "MG"
        }
    ]
}